Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Apr 14;14(14):2142-61.
doi: 10.3748/wjg.14.2142.

Necrotizing enterocolitis: a multifactorial disease with no cure

Kareena-L Schnabl  1 , John-E Van Aerde, Alan-Br Thomson, Michael-T Clandinin
Affiliations
Review

Necrotizing enterocolitis: a multifactorial disease with no cure

Kareena-L Schnabl et al. World J Gastroenterol. .

Abstract

Necrotizing enterocolitis is an inflammatory bowel disease of neonates with significant morbidity and mortality in preterm infants. Due to the multifactorial nature of the disease and limitations in disease models, early diagnosis remains challenging and the pathogenesis elusive. Although preterm birth, hypoxic-ischemic events, formula feeding, and abnormal bacteria colonization are established risk factors, the role of genetics and vasoactive/inflammatory mediators is unclear. Consequently, treatments do not target the specific underlying disease processes and are symptomatic and surgically invasive. Breast-feeding is the most effective preventative measure. Recent advances in the prevention of necrotizing enterocolitis have focused on bioactive nutrients and trophic factors in human milk. Development of new disease models including the aspect of prematurity that consistently predisposes neonates to the disease with multiple risk factors will improve our understanding of the pathogenesis and lead to discovery of innovative therapeutics.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pathophysiology of necrotizing enterocolitis (NEC).
Figure 2
Figure 2
LPS-Induced signaling pathways leading to NF-κB activation.
Figure 3
Figure 3
Metabolic pathways of arachidonic acid and eicosanoid production.
See this image and copyright information in PMC

References

    1. Lin PW, Stoll BJ. Necrotising enterocolitis. Lancet. 2006;368:1271–1283. - PubMed
    1. Lee JS, Polin RA. Treatment and prevention of necrotizing enterocolitis. Semin Neonatol. 2003;8:449–459. - PMC - PubMed
    1. Updegrove K. Necrotizing enterocolitis: the evidence for use of human milk in prevention and treatment. J Hum Lact. 2004;20:335–339. - PubMed
    1. Martin CR, Walker WA. Intestinal immune defences and the inflammatory response in necrotising enterocolitis. Semin Fetal Neonatal Med. 2006;11:369–377. - PubMed
    1. Henry MC, Lawrence Moss R. Surgical therapy for necrotizing enterocolitis: bringing evidence to the bedside. Semin Pediatr Surg. 2005;14:181–190. - PubMed

Publication types